L-641,953 (R-8-fluoro-dibenzo[b, f]thiepin-3-carboxylic acid-5-oxide): a novel thromboxane–prostaglandin endoperoxide antagonist
- 1 April 1987
- journal article
- research article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 65 (4) , 509-514
- https://doi.org/10.1139/y87-087
Abstract
The effects of L-641,953 (R-8-fluoro-dibenzo[b,f]thiepin-3-carboxylic acid-5-oxide) have been studied on pulmonary and other smooth muscle preparations in vitro and in vivo. When studied in vitro on guinea-pig tracheal chains. L-641,933 produced significant shifts in the dose-response curves to the prostaglandin endoperoxide analogues. U-44069 (pA2 7.06) and U-46619 (pA2 7.14), and prostaglandin (PG) F2.alpha. (pA2 6.33) had minimal activity against contractions induced by histamine (pA2 4.38), 5-hydroxytryptamine (pA2 4.63), and acetylcholine (pA2 4.56) and slightly enhanced relaxation induced by PGE2. When tested on the guinea-pig gall bladder strip in vitro, L-641,953 antagonized contractions induced by U-44069 (pA2 7.03) but was less active against those induced by PGF2.alpha. (pA2 6.03), PGE1 (pA2 5.62), and histamine (pA2 4.84). When tested in vitro on the guinea-pig pulmonary artery, L-651-953 significantly antagonized contractions induced by U-44069 (pA2 7.04), U-46619 (pA2 7.14), and PGF2.alpha. (pA2 7.16) but was less effective against contractions induced by histamine (pA2 4.19). Schild analysis indicated that L-641,953 was fully competitive against contractions of either the guinea-pig tracheal chain induced by U-46619 or the guinea-pig pulmonary artery induced by U-44069 and U-46619. When tested on human platelets in vitro L-641,953 inhibited aggregation induced by U-44069 (ED50 0.026 mg/kg) but not histamine in the guinea pig and U-44069 (ED50 0.15 mg/kg) but not histamine or PGF2.alpha. in the dog. When L-641,953 was administered by the intraduodenal route to dogs (3 mg/kg) significant inhibition of bronchoconstriction induced by U-44069 or arachidonic acid was observed with a duration of action .gtorsim. 3 h. It is concluded that L-641,953 is a novel, relatively selective, and orally active antagonist of the thromboxane-prostaglandin endoperoxide receptor.This publication has 12 references indexed in Scilit:
- PHARMACOLOGIC CHARACTERIZATION OF HUMAN AND CANINE THROMBOXANE-A2 PROSTAGLANDIN H2-RECEPTORS IN PLATELETS AND BLOOD-VESSELS - EVIDENCE FOR DIFFERENT RECEPTORS1985
- Studies on L‐640,035: a novel antagonist of contractile prostanoids in the lungBritish Journal of Pharmacology, 1984
- Investigations on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human plateletsThrombosis Research, 1984
- INHIBITION OF PROSTANOID-MEDIATED PLATELET-AGGREGATION INVIVO AND INVITRO BY "3-HYDROXYMETHYL-DIBENZO(B,F)THIEPIN 5,5-DIOXIDE (L-640,035)1984
- SK-AND-F 88046 - A UNIQUE PHARMACOLOGIC ANTAGONIST OF BRONCHOCONSTRICTION INDUCED BY LEUKOTRIENE-D4, THROMBOXANE AND PROSTAGLANDIN-F2-ALPHA AND PROSTAGLANDIN-D2 INVITRO1984
- Contraction of guinea pig gail bladder strips by leukotrienes and other agonistsProstaglandins, 1983
- Studies of the characterisation of prostanoid receptors: A proposed classificationProstaglandins, 1982
- Specific receptors for prostaglandins in airwaysProstaglandins, 1980
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- THE PHYSIOLOGIC AND PHARMACOLOGIC CHARACTERISTICS OF THE TRACHEAL MUSCLE1959